NeuroTraX-AI targets the blood-brain barrier, a central hurdle in brain medicine and drug safety, as U.S. regulators ...
RAG-17 is an experimental RNA-targeting therapy designed to lower toxic SOD1 protein in people with SOD1-ALS. A six-person trial found RAG-17 was well tolerated, with no serious side effects. RAG-17 ...
KATY, TX / ACCESS Newswire / July 20, 2026 / As life science research grows more refined and diversified, antibodies are no ...
Cholibrium combines ten mushroom extracts targeting heart health as Reishi and Shiitake cardiovascular research matures ...
Tuberculosis meningitis treatment may be approaching a turning point: a Cincinnati Children's-led study in Nature Communications finds semaglutide — the diabetes drug sold as Ozempic — outperforms ...
The Institute of Food Technologists convened its annual event and expo, IFT FIRST, at McCormick Place from July 12 to 15, ...
Consumer products and food alertsHere is a roundup of newly announced recalls and safety warnings affecting home goods, ...
According to MarketsandMarkets™, the omega-3 market is projected to grow from USD 4.88 billion in 2026 and to reach USD 8.73 ...
Morning Overview on MSN
A CRISPR treatment restored some sight to a woman born nearly blind
A woman born with almost no functional vision because of a genetic mutation has regained measurable sight after a single ...
There's nuance to this one.
According to MarketsandMarkets, the omega-3 market is projected to grow from USD 4.88 billion in 2026 and to reach USD 8.73 billion by 2031 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results